Screening for Fibrosis Promotes Lifestyle Changes: A Prospective Cohort Study in 4796 IndividualsMaria Kjærgaard, Maja Thiele, Nikolaj Torp et al.|Clinical Gastroenterology and Hepatology|2023Cited by 54
Development, validation, and prognostic evaluation of LiverPRO for the prediction of significant liver fibrosis in primary care: a prospective cohort studyKatrine Prier Lindvig, Maja Thiele, Camilla Dalby Hansen et al.|The Lancet. Gastroenterology & hepatology|2024Cited by 35
Steatotic Liver Disease Classification Is Dynamic, Affecting Clinical Trial Eligibility and Subclass-Specific TreatmentsMads Israelsen, Aleksander Krag, Camilla Dalby Hansen et al.|Clinical Gastroenterology and Hepatology|2025Cited by 33
Phosphatidylethanol and self-reported alcohol intake to subclassify individuals at risk of steatotic liver disease: an analysis of data from a prospective cohort studyNikolaj Torp, Maja Thiele, Camilla Dalby Hansen et al.|The Lancet. Gastroenterology & hepatology|2025Cited by 25
Prevalence, severity and determinants of steatotic liver disease among individuals with metabolic and alcohol risk from the communityCamilla Dalby Hansen, Maja Thiele, Katrine Holtz Thorhauge et al.|Journal of Hepatology|2025Cited by 14